glp-1 intestinal paralysis law firm in michigan What Gastrointestinal Side Effects Qualify for Ozempic Lawsuits? Ozempic Lawsuit: July 2026 Blindness

Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.

Learn why dietitian support is vital for reducing side effects, protecting nutrition.

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.

You can increase it through fiber-rich foods, exercise, and sleepbut some people need medication to reach their goals

The Semaglutide Weight Loss Program is a clinician-guided telehealth program built around compounded semaglutide, a GLP-1 medication that supports appetite control, quiets food noise, and makes a calorie deficit easier to sustain

The GLP-1 market is led by semaglutide products Ozempic and Wegovy (Novo Nordisk) and tirzepatide products Mounjaro and Zepbound (Lilly)